Stocktoria

Orthofix Medical Inc. OFIX

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1992-04-24

Orthofix Medical Inc. statistics & valuation

Market cap$395.3M
P / S0.5×
P / B0.9×
Net margin-11.2%
Return on equity-20.5%
Net debt$75.4M
Enterprise value USD$470.7M
Earnings yield EBIT/EV-17.3%
Return on capital-12%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
0.70% 1.40% 3.00% -6.20% 0.60% -8.30% -4.30% -20.30% -15.80% -11.20% 2016201720182019202020212022202320242025
Gross margin (%)
78.60% 78.60% 78.70% 78.10% 74.90% 75.30% 73.20% 65.10% 68.30% 68.80% 2016201720182019202020212022202320242025
Operating margin (%)
5.10% 9.40% 6.60% -4.10% -1.50% -1.80% -2.90% -18.60% -10.60% -9.90% 2016201720182019202020212022202320242025
Return on equity (%)
1.20% 2.10% 4.10% -8.70% 0.70% -11.40% -5.90% -25.30% -25.00% -20.50% 2016201720182019202020212022202320242025
Shares outstanding
18.5M 18.5M 18.9M 19.4M 19.4M 19.8M 20.2M 37.2M 38.5M 39.8M 2016201720182019202020212022202320242025
Net debt ($)
$61.2M $73.8M $75.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
0.80% 1.50% 3.00% -5.70% 0.50% -8.10% -4.30% -16.40% -14.10% -10.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
10.40% 5.60% 8.00% 2.80% 14.50% 0.10% -7.10% -14.20% 2016201720182019202020212022202320242025
Debt / equity (×)
0.16× 0.31× 0.35× 2016201720182019202020212022202320242025
EPS ($)
$0.17 $0.34 $0.72 -$1.51 $0.13 -$1.95 -$0.98 -$4.12 -$3.30 -$2.33 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Orthofix Medical Inc. trades at about 80× earnings — below its 10-year norm (10-year range 17.3×–310.8×, median 168.9×).

17.3× 310.8×

Shaded band = 10-year range (17.3×–310.8×); dot = today's 80×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin68.8%68.3%65.1%73.2%75.3%74.9%78.1%78.7%78.6%78.6%
Operating margin-9.9%-10.6%-18.6%-2.9%-1.8%-1.5%-4.1%6.6%9.4%5.1%
Net margin-11.2%-15.8%-20.3%-4.3%-8.3%0.6%-6.2%3.0%1.4%0.7%
FCF margin——-14.2%-7.1%0.1%14.5%2.8%8.0%5.6%10.4%
Return on assets-10.8%-14.1%-16.4%-4.3%-8.1%0.5%-5.7%3.0%1.5%0.8%
Return on equity-20.5%-25.0%-25.3%-5.9%-11.4%0.7%-8.7%4.1%2.1%1.2%
Debt / equity0.35×0.31×0.16×———————
Current ratio2.452.572.543.062.552.603.072.853.172.33

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.